[Form 4] Ovintiv Inc. Insider Trading Activity
Ovintiv Inc. (OVV) reported a director’s equity transaction on Form 4.
Rhea-AI Filing Summary
Ovintiv Inc. (OVV) reported a director’s equity transaction on Form 4. On November 10, 2025, the reporting person acquired 740 Deferred Share Units (DSUs) at a reported price of $0, reflecting a board equity award rather than an open‑market purchase. Following this grant, the reporting person beneficially owns 10,621 derivative securities, held directly.
Each DSU is the economic equivalent of one share of Ovintiv common stock, accrues dividend‑equivalent DSUs, and is held until the individual retires from the Board.
Positive
- None.
Negative
- None.
Insights
Routine director DSU award; neutral governance disclosure.
Ovintiv disclosed a standard board compensation item: an award of 740 DSUs on November 10, 2025 at a reported price of $0, consistent with non-cash director grants. DSUs are economically equivalent to common shares and accumulate dividend‑equivalent DSUs.
The filing shows total derivative securities beneficially owned at 10,621, held directly. This is administrative and typical for public company boards. Actual impact depends on future vesting/board tenure mechanics stated: DSUs are held until retirement from the Board.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Deferred Share Unit | 740 | $0.00 | $0.00 |
Footnotes (1)
- F1. Each Deferred Share Unit ("DSU") is the economic equivalent of one share of common stock of Ovintiv Inc. and yields dividend equivalent DSUs. DSUs are held until retirement from the Board.
FAQ
What did Ovintiv (OVV) disclose in this Form 4?
How many DSUs were awarded and at what price?
How many derivative securities does the reporting person own after the transaction?
When will the DSUs be settled?
Was this an open‑market purchase?
AI-generated analysis. How Rhea-AI works. Not financial advice.